Co-Authors
This is a "connection" page, showing publications co-authored by HUSSEIN TAWBI and IAN E MCCUTCHEON.
Connection Strength
0.355
-
Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2024 Jun; 30(6):1787.
Score: 0.060
-
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neurooncol Pract. 2024 Aug; 11(4):452-463.
Score: 0.059
-
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320.
Score: 0.056
-
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med. 2023 04; 29(4):898-905.
Score: 0.055
-
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions. Pigment Cell Melanoma Res. 2020 07; 33(4):527-541.
Score: 0.044
-
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. 2019 May; 142(3):499-509.
Score: 0.042
-
Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2. ESMO Open. 2018; 3(1):e000283.
Score: 0.039